Pharma Deko Statistics

Total Valuation

Pharma Deko has a market cap or net worth of NGN 396.98 million.

Market Cap	396.98M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharma Deko has 216.93 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	216.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
PB Ratio	0.34
P/TBV Ratio	0.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.03.

Current Ratio	0.21
Quick Ratio	0.03
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-13.37

Financial Efficiency

Return on equity (ROE) is -11.45% and return on invested capital (ROIC) is -6.55%.

Return on Equity (ROE)	-11.45%
Return on Assets (ROA)	-3.65%
Return on Capital (ROIC)	-6.55%
Revenue Per Employee	6.71M
Profits Per Employee	-2.02M
Employee Count	70
Asset Turnover	0.21
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.83
200-Day Moving Average	1.83
Relative Strength Index (RSI)	41.10
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Deko had revenue of NGN 469.58 million and -141.61 million in losses. Loss per share was -0.65.

Revenue	469.58M
Gross Profit	34.37M
Operating Income	-132.32M
Pretax Income	-141.61M
Net Income	-141.61M
EBITDA	-63.29M
EBIT	-132.32M
Loss Per Share	-0.65

Full Income Statement

Balance Sheet

The company has 9.21 million in cash and 31.78 million in debt, giving a net cash position of -22.57 million or -0.10 per share.

Cash & Cash Equivalents	9.21M
Total Debt	31.78M
Net Cash	-22.57M
Net Cash Per Share	-0.10
Equity (Book Value)	1.17B
Book Value Per Share	5.38
Working Capital	-764.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.85 million and capital expenditures -4.47 million, giving a free cash flow of -48.32 million.

Operating Cash Flow	-43.85M
Capital Expenditures	-4.47M
Free Cash Flow	-48.32M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross margin is 7.32%, with operating and profit margins of -28.18% and -30.16%.

Gross Margin	7.32%
Operating Margin	-28.18%
Pretax Margin	-30.16%
Profit Margin	-30.16%
EBITDA Margin	-13.48%
EBIT Margin	-28.18%
FCF Margin	n/a

Dividends & Yields

Pharma Deko does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-35.67%
FCF Yield	-12.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharma Deko has an Altman Z-Score of -0.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.86
Piotroski F-Score	n/a